Databases are essential tools for pharmacoeconomic research. While North America has large administrative claims databases, hospital databases, and electronic medical record systems, databases in Europe are scarcer, integrated primary and secondary care data are rare, and claims with corresponding cost values are largely non-existent.
Biosimilar agents are similar but non-identical versions of existing biological drugs and may be authorized for use once the patent on the reference product has expired. Based on a recent market forecast of IMS, biosimilars are forecasted to deliver total savings of as much as $110 billion to health systems across Europe and the U.S. through 2020.
At the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting, conducted May 21-25, 2-16, in Washington, DC, industry professionals convened to delve into the topic “Value, Affordability, and Patient Centeredness: Can We Have it All?” UBC’s Value Demonstration experts joined the conversation with five abstracts highlighting some of their recentresearch.
There is increasing demand from payers to gather evidence on the safety of medications used in the general population post-commercialization. Conducting a literature review involving critical appraisal is essential to better understand the research topic and assess the validity of the research findings. UBC can conduct literature reviews and other real-world evidence generation studies for your product.
Pediatric vaccine administration cost is one major, indirect component of the full pediatric vaccination cost. The UBC team undertook a literature review to understand the cost range for pediatric vaccine administration across different countries and to describe the costing methodologies employed for its calculation.
Evidentiary requirements in support of market access and reimbursement span the entire drug development lifecycle. A critical evidence gathering approach includes one or more reviews of literature to leverage published data on epidemiological outcomes, effectiveness, safety, burden and cost of illness, and health care utilization and care processes. These four key considerations will drive successful literature reviews.